SCHEMBL6134440

SCHEMBL6134440

COC(=O)c1ccc(C(=O)NNC(=O)c2ccc(N3CCN(C4CCC5(CC4)OCCO5)CC3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 4/20 0.41
TDP1 Q9NUW8 1/20 0.41
HDAC3 O15379 7/20 0.41
HDAC8 Q9BY41 7/20 0.41
POLB P06746 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
MBTD1 Q05BQ5 1/20 0.40
TP53BP1 Q12888 1/20 0.40
L3MBTL4 Q8NA19 1/20 0.40
L3MBTL3 Q96JM7 1/20 0.40
MAPT P10636 2/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
MGLL Q99685 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6135040 0.91 SMN1; SMN2 (0.43) KMT2AMEN1ALDH1A1KDM4ETDP1
SCHEMBL6134612 0.87 ALDH1A1 (0.49) KMT2AMEN1ALDH1A1KDM4ETDP1
SCHEMBL6134378 0.87 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1HDAC3HDAC8
SCHEMBL6134229 0.84 HRH3 (0.44) KMT2AMEN1ALDH1A1KDM4ETDP1
SCHEMBL6134989 0.84 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1KDM4ETDP1
SCHEMBL6134210 0.84 MEN1 (0.46) KMT2AMEN1HDAC3HDAC8POLB
SCHEMBL6134631 0.83 HDAC3 (0.50) KMT2AMEN1ALDH1A1KDM4ETDP1
SCHEMBL6134434 0.83 ALDH1A1 (0.49) KMT2AMEN1ALDH1A1TDP1POLB
SCHEMBL6134863 0.82 KMT2A (0.51) KMT2AMEN1ALDH1A1KDM4ETDP1
SCHEMBL15238296 0.81 ALDH1A1 (0.57) KMT2AMEN1ALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 KMT2A 4492/4885MEN1 880/4885ALDH1A1 3841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.